Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mohammed S. Ikram is active.

Publication


Featured researches published by Mohammed S. Ikram.


Oncogene | 2002

Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma

Gerhard Regl; Graham W. Neill; Thomas Eichberger; Maria Kasper; Mohammed S. Ikram; Josef Koller; Helmut Hintner; Anthony G. Quinn; Anna-Maria Frischauf; Fritz Aberger

Transgenic mouse models have provided evidence that activation of the zinc-finger transcription factor GLI1 by Hedgehog (Hh)-signalling is a key step in the initiation of the tumorigenic programme leading to Basal Cell Carcinoma (BCC). However, the downstream events underlying Hh/GLI-induced BCC development are still obscure. Using in vitro model systems to analyse the effect of Hh/GLI-signalling in human keratinocytes, we identified a positive feedback mechanism involving the zinc finger transcription factors GLI1 and GLI2. Expression of GLI1 in human keratinocytes induced the transcriptional activator isoforms GLI2α and GLI2β. Both isoforms were also shown to be expressed at elevated levels in 21 BCCs compared to normal skin. Detailed time course experiments monitoring the transcriptional response of keratinocytes either to GLI1 or to GLI2 suggest that GLI1 is a direct target of GLI2, while activation of GLI2 by GLI1 is likely to be indirect. Furthermore, expression of either GLI2 or GLI1 led to an increase in DNA-synthesis in confluent human keratinocytes. Taken together, these results suggest an important role of the positive GLI1-GLI2 feedback loop in Hh-mediated epidermal cell proliferation.


Oncogene | 2004

The zinc-finger transcription factor GLI2 antagonizes contact inhibition and differentiation of human epidermal cells

Gerhard Regl; Maria Kasper; Harald Schnidar; Thomas Eichberger; Graham W. Neill; Mohammed S. Ikram; Anthony G. Quinn; Michael P. Philpott; Anna-Maria Frischauf; Fritz Aberger

In stratified epidermis, activation of the Hh/Gli signal transduction pathway has been implicated in the control of cell proliferation and tumorigenesis. The zinc-finger transcription factor Gli2 has been identified as critical mediator of the Hh signal at the distal end of the pathway, but the molecular mechanisms by which Gli2 regulates cell proliferation or induces epidermal malignancies such as basal cell carcinoma are still unclear. Here, we provide evidence for a role of human GLI2 in antagonizing contact inhibition and epidermal differentiation. We show by gene expression profiling that activation of the GLI2 oncogene in human keratinocytes activates the transcription of a number of genes involved in cell cycle progression such as E2F1, CCND1, CDC2 and CDC45L, while it represses genes associated with epidermal differentiation. Analysis of the proliferative effect of GLI2 revealed that GLI2 is able to induce G1–S phase progression in contact-inhibited keratinocytes. Detailed time-course experiments identified E2F1 as early transcriptional target of GLI2. Further, we show that GLI2 expression in human keratinocytes results in a marked downregulation of epidermal differentiation markers. The data suggest a role for GLI2 in Hh-induced epidermal neoplasia by opposing epithelial cell cycle arrest signals and epidermal differentiation.


British Journal of Cancer | 2006

Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours

J. Green; Mohammed S. Ikram; Jashmin J. Vyas; N Patel; C Proby; Lucy Ghali; Irene M. Leigh; Edel A. O'Toole; Alan Storey

The molecular mechanisms that underlie the development of squamous cell skin cancers (SSC) are poorly understood. We have used oligonucleotide microarrays to compare the differences in cellular gene expression between a series of keratinocyte cell that mimic disease progression with the aim of identifying genes that may potentially contribute towards squamous cell carcinoma (SCC) progression in vivo, and in particular to identify markers that may serve as potential therapeutic targets for SCC treatment. Gene expression differences were corroborated by polymerase chain reaction and Western blotting. We identified Axl, a receptor tyrosine kinase with transforming potential that has also been shown to have a role in cell survival, adhesion and chemotaxis, was upregulated in vitro in SCC-derived cells compared to premalignant cells. Extending the investigation to tumour biopsies showed that the Axl protein was overexpressed in vivo in a series of SCCs.


Stem Cells | 2007

Stem/Progenitor Cell‐Like Properties of Desmoglein 3dim Cells in Primary and Immortalized Keratinocyte Lines

Hong Wan; Ming Yuan; Cathy Simpson; Kirsty Allen; Felicity N.E. Gavins; Mohammed S. Ikram; S Basu; Nuzhat Baksh; Edel A. O'Toole; Ian R. Hart

We showed previously that primary keratinocytes selected for low desmoglein 3 (Dsg3) expression levels exhibited increased colony‐forming efficiency and heightened proliferative potential relative to cells with higher Dsg3 expression levels, characteristics consistent with a more “stem/progenitor cell‐like” phenotype. Here, we have confirmed that Dsg3dim cells derived from cultured primary human adult keratinocytes have comparability with α6bri/CD71dim stem cells in terms of colony‐forming efficiency. Moreover, these Dsg3dim cells exhibit increased reconstituting ability in in vitro organotypic culture on de‐epidermalized dermis (DED); they are small, actively cycling cells, and they express elevated levels of various p63 isoforms. In parallel, using the two immortalized keratinocyte cell lines HaCaT and NTERT, we obtained essentially similar though occasionally different findings. Thus, reduced colony‐forming efficiency by Dsg3bri cells consistently was observed in both cell lines even though the cell cycle profile and levels of p63 isoforms in the bri and dim populations differed between these two cell lines. Dsg3dim cells from both immortalized lines produced thicker and better ordered hierarchical structural organization of reconstituted epidermis relative to Dsg3bri and sorted control cells. Dsg3dim HaCaT cells also show sebocyte‐like differentiation in the basal compartment of skin reconstituted after a 4‐week organotypic culture. No differences in percentages of side population cells (also a putative marker of stem cells) were detected between Dsg3dim and Dsg3bri populations. Taken together our data indicate that Dsg3dim populations from primary human adult keratinocytes and long‐term established keratinocyte lines possess certain stem/progenitor cell‐like properties, although the side population characteristic is not one of these features.


Cell Death and Disease | 2014

GLI2 induces genomic instability in human keratinocytes by inhibiting apoptosis.

Eleni Pantazi; Emilios Gemenetzidis; Giuseppe Trigiante; Gary Warnes; Xueying Mao; Mohammed S. Ikram; Muy-Teck Teh; Yong-Jie Lu; Michael P. Philpott

Abnormal Sonic Hedgehog signalling leads to increased transcriptional activation of its downstream effector, glioma 2 (GLI2), which is implicated in the pathogenesis of a variety of human cancers. However, the mechanisms underlying the tumorigenic role of GLI2 remain elusive. We demonstrate that overexpression of GLI2-β isoform, which lacks the N-terminal repressor domain (GLI2ΔN) in human keratinocytes is sufficient to induce numerical and structural chromosomal aberrations, including tetraploidy/aneuploidy and chromosomal translocations. This is coupled with suppression of cell cycle regulators p21WAF1/CIP1 and 14-3-3σ, and strong induction of anti-apoptotic signalling, resulting in a reduction in the ability to eliminate genomically abnormal cells. Overexpression of GLI2ΔN also rendered human keratinocytes resistant to UVB-mediated apoptosis, whereas inhibition of B-cell lymphoma 2 (BCL-2) restored endogenous (genomic instability (GIN)) and exogenous (UVB) DNA damage-induced apoptosis. Thus, we propose that ectopic expression of GLI2 profoundly affects the genomic integrity of human epithelial cells and contributes to the survival of progenies with genomic alterations by deregulating cell cycle proteins and disabling the apoptotic mechanisms responsible for their elimination. This study reveals a novel role for GLI2 in promoting GIN, a hallmark of human tumors, and identifies potential mechanisms that may provide new opportunities for the design of novel forms of cancer therapeutic strategies.


Journal of Investigative Dermatology | 2004

GLI2 Is Expressed in Normal Human Epidermis and BCC and Induces GLI1 Expression by Binding to its Promoter

Mohammed S. Ikram; Graham W. Neill; Gerhard Regl; Thomas Eichberger; Anna-Maria Frischauf; Fritz Aberger; Anthony G. Quinn; Michael P. Philpott


The Journal of Clinical Endocrinology and Metabolism | 2008

Granulosa cell survival and proliferation are altered in polycystic ovary syndrome.

M. Das; O. Djahanbakhch; B. Hacihanefioglu; Ertan Saridogan; Mohammed S. Ikram; Lucy Ghali; M. Raveendran; Alan Storey


Journal of Investigative Dermatology | 2004

FOXE1, A New Transcriptional Target of GLI2 Is Expressed in Human Epidermis and Basal Cell Carcinoma

Thomas Eichberger; Gerhard Regl; Mohammed S. Ikram; Graham W. Neill; Michael P. Philpott; Fritz Aberger; Anna-Maria Frischauf


Cancer Research | 2003

Loss of protein kinase calpha expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma

Graham W. Neill; Lucy Ghali; Judith L. Green; Mohammed S. Ikram; Michael P. Philpott; Anthony G. Quinn


Carcinogenesis | 2008

GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes

Graham W. Neill; Wesley J. Harrison; Mohammed S. Ikram; Tomos Williams; Lucia S. Bianchi; Sandeep K. Nadendla; Judith L. Green; Lucy Ghali; Anna-Maria Frischauf; Edel A. O'Toole; Fritz Aberger; Michael P. Philpott

Collaboration


Dive into the Mohammed S. Ikram's collaboration.

Top Co-Authors

Avatar

Graham W. Neill

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar

Michael P. Philpott

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alan Storey

John Radcliffe Hospital

View shared research outputs
Top Co-Authors

Avatar

Edel A. O'Toole

Queen Mary University of London

View shared research outputs
Researchain Logo
Decentralizing Knowledge